MANGOCEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Mangoceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q3 2024.
  • Mangoceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2M, a 11.1% decline year-over-year.
  • Mangoceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$9.33M, a 27.4% decline year-over-year.
  • Mangoceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$9.21M, a 361% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$9.33M -$2M -$200K -11.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$9.13M -$2.39M -$107K -4.68% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$9.02M -$2.37M +$193K +7.55% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$9.21M -$2.57M -$1.89M -281% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$7.32M -$1.8M -$805K -80.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$6.51M -$2.28M -$1.97M -636% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$4.54M -$2.56M -$2.54M -12966% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$2M -$673K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$995K Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 -$310K Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-27
Q1 2022 -$19.6K Jan 1, 2022 Mar 31, 2022 10-Q 2023-10-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.